|
ALLO Allogene Therapeutics Inc 1737287 |
| Balance Sheet |
|
Current Assets
|
$340,000,000.00 |
|
Assets
|
$550,091,000.00 |
|
Current Liabilities
|
$31,727,000.00 |
|
Liabilities
|
$113,916,000.00 |
|
Equity
|
$436,175,000.00 |
|
Shares Out
|
345345427.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-44,909,000.00 |
|
Investing Cash Flow
|
$-177,147,000.00 |
| Market Analysis |
Market Cap
|
$725,225,396.70 |
|
Price
|
$2.10 |
|
BVPS
|
1.26 |
|
PB
|
1.67 |
|
EPS
|
-0.13 |
|
PS
|
39.07 |
|
FCF
|
$-45,068,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:37 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:28 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.17 |
|
|
2026-05-13 |
-0.18 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.23 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.19 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALLO documents filed with the SEC.
ALLO Filings
Clear
